Correlation Between Morgan Stanley and Jazz Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Jazz Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Jazz Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley Direct and Jazz Pharmaceuticals plc, you can compare the effects of market volatilities on Morgan Stanley and Jazz Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Jazz Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Jazz Pharmaceuticals.

Diversification Opportunities for Morgan Stanley and Jazz Pharmaceuticals

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Morgan and Jazz is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Jazz Pharmaceuticals plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jazz Pharmaceuticals plc and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Jazz Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jazz Pharmaceuticals plc has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Jazz Pharmaceuticals go up and down completely randomly.

Pair Corralation between Morgan Stanley and Jazz Pharmaceuticals

Given the investment horizon of 90 days Morgan Stanley is expected to generate 2.78 times less return on investment than Jazz Pharmaceuticals. But when comparing it to its historical volatility, Morgan Stanley Direct is 2.02 times less risky than Jazz Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Jazz Pharmaceuticals plc is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  9,782  in Jazz Pharmaceuticals plc on September 23, 2024 and sell it today you would earn a total of  1,903  from holding Jazz Pharmaceuticals plc or generate 19.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.48%
ValuesDaily Returns

Morgan Stanley Direct  vs.  Jazz Pharmaceuticals plc

 Performance 
       Timeline  
Morgan Stanley Direct 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Jazz Pharmaceuticals plc 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Jazz Pharmaceuticals plc are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Jazz Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Morgan Stanley and Jazz Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Morgan Stanley and Jazz Pharmaceuticals

The main advantage of trading using opposite Morgan Stanley and Jazz Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Jazz Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jazz Pharmaceuticals will offset losses from the drop in Jazz Pharmaceuticals' long position.
The idea behind Morgan Stanley Direct and Jazz Pharmaceuticals plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities